How would ASTRO’s Strategic Plan inspire you (your leadership) as an ASTRO Board Member?

As a 30-year ASTRO member and volunteer, I have long felt that every professional action is integral to moving our specialty forward. Each of us is a representative and ambassador in our field. In our daily clinical activities, as members of medical staffs, through our research and in other outward facing activities, we individually and collectively influence the public perception of radiation oncology. ASTRO, as our professional society, also reaches out to its members and the oncology field at large on behalf of our specialty. The actions of ASTRO, like many organizations, are directed by the guidance of the Strategic Plan, a reflection of the organization’s vision.

The Strategic Plan of ASTRO is the quintessence of our daily activities leveraged across our specialty to enhance our voices and to support the goals of ASTRO. To deliver high-quality care and value leading to excellent outcomes, to shape health policy and support our members, to advance equitable oncology care and cultivate a diverse work force, and to be an equal partner among the multidisciplinary voices of oncology embody the implementation of the plan.

We take inspiration from the vision offered by the ASTRO Strategic Plan and its bold view of the near term and longer-term future of radiation oncology. ASTRO’s vision inspires me to move forward these specific goals: to communicate – as peers – with other oncologic organizations, to support and expand the research that delivers better treatments for our future patients, and to work with the governmental entities that shape the future of America’s health care as an advocate for radiation oncology.

How would ASTRO’s Strategic Plan inspire you (your leadership) as an ASTRO Board Member?

ASTRO’s Strategic Plan, approved in 2017 and updated in 2022, inspires me to continue the drive for high-quality care with appropriate reimbursement, policy advocacy to reduce administrative burdens, and fuller engagement with the oncology community. I am particularly interested in the strategic goal to empower future generations of diverse radiation oncologists through innovative education, research funding and engagement with members from the earliest years of their careers. I am seeking the position of ASTRO’s Secretary/Treasurer to continue the work of keeping membership well informed of activities and finances, and to continue to develop volunteers to represent our organization in areas related to reimbursement and health policy. It is essential that we mentor any members who are interested in pursuing policy advocacy for the benefit of our specialty and our patients. I am confident that, by providing guidance and opportunity to younger members, we can achieve the updated goals of ASTRO’s Strategic Plan.

The following abbreviated summary of my service to ASTRO may be helpful:

• Finance and Audit Committee (2016 – 2021)
• Payment Systems Committee (2007 – 2013, Vice-chair 2008-2009)
• Code Development and Valuation Committee (2007 – 2021, Chair 2007-2012)
• Nominating Committee (2017-2019)
• Health Policy Committee (2007-2022, Co-chair 2013-2015)
• ASTRO’s advisor to the AMA RVS Update Committee (2007 – present)
• ASTRO’s Board of Directors Health Policy Council representative (2015-2019)

My tenure as a member of ASTRO’s Finance and Audit Committee was under the three recent Secretary/Treasurers who served as my mentors.

In addition to service to ASTRO, I continue to serve as Chair of a large department with direct fiscal responsibility for the budget, and as a member of the hospital’s clinical practice plan board with similar deliverables. I understand the time commitment required for the role of ASTRO’s Secretary/Treasurer.

Since ASTRO’s financial management is directly tied to the work of the Finance/Audit Committee, the execution of these responsibilities has a significant impact on supporting our strategic plan. I have long encouraged any ASTRO member who has an interest and skills in finance and a willingness to ask questions, to become a Board Committee member. I will continue to encourage involvement of ASTRO members, transparency in all financial matters, and support of the work of the dedicated ASTRO staff.

How would ASTRO’s Strategic Plan inspire you (your leadership) as an ASTRO Board Member?

I feel fortunate to be part of this amazing field of medicine and am honored to be considered for a position on the ASTRO Board representing the Clinical Affairs and Quality Council (CAQC).
 
As a candidate to become a member of the ASTRO Board, I am enthusiastic about the ASTRO Strategic Plan and believe it provides an important framework for radiation oncology to strengthen its role in cancer care, continue to improve as an inclusive and cohesive specialty with participation and engagement of all, and facilitate delivery of high-quality and equitable care for our patients.
 
Radiation oncology is and has been for many years a leader in quality and safety. With the increasing complexity of care, we must continue to have robust quality and safety programs and clinical standards and guidelines. We must also be agile so that these efforts are kept current. I have been involved with the Clinical Affairs and Quality Council for several years and believe continued support of these efforts is a critical piece to achieving the strategic goals of both driving high quality care and access to equitable care. I will do my best as a Board member and representative of the CAQC to advance these programs.  
 
The goal to foster a diverse workforce is a critically important one both for ASTRO and for all of us as individuals and members of our work organizations and our communities. It is imperative that we as leaders of ASTRO be proactive in efforts to have our committees, task forces and groups representing ASTRO reflect the makeup of both our membership and of the patients we care for.
 
I am excited about the future of cancer care and the essential role radiation oncology has as a leader in oncology. It is an honor and a responsibility to be elected to serve as a member of the ASTRO Board and if elected, I will do my best to represent our members and our specialty.

I am currently Professor, Vice-chair of Clinical Operations at The Ohio State University Department of Radiation Oncology. I was recruited to OSU to become Clinical Director arriving in December 2006. Prior to joining Ohio State, I was the Division Head of Radiation Oncology at The Lexington Clinic, a 150+ multispecialty physician practice based in Lexington, Kentucky. I did my radiation oncology residency at the University of Iowa and for the first 7 years of practice was on active duty in the U.S. Navy and assigned to Naval Medical Center, Portsmouth, Virginia. I was department head at the time of my departure from active duty. I completed 20 years in the Navy on active duty or reserve, retiring in 2007 at the rank of Captain.

Education

• MD, University of South Dakota School of Medicine, Vermillion, South Dakota, 1987
• BS, Chemical Engineering, South Dakota School of Mines, Rapid City, South Dakota, 1981

Postgraduate Education

• Resident, Radiation Oncology, University of Iowa, Iowa City, Iowa, 1991 - 1995
• Internship, Internal Medicine, Naval Medical Center, San Diego, 1986 - 1987

Academic Appointments

• Professor, Radiation Oncology, The Ohio State University Medical Center 2019 - present
• Associate Professor, Radiation Oncology, The Ohio State University Medical Center, 2012 - 2019
• Assistant Professor, Radiation Oncology, The Ohio State University Medical Center, 2006 - 2012

Hospital Appointments

• Vice-chair, Clinical Operations, Department of Radiation Oncology, The Ohio State University Medical Center, 2018-present
• Clinical Director, Department of Radiation Oncology, The Ohio State University Medical Center, 2006 - present
• Chair, The Ohio State University Radiation Safety Committee, July 2015 – June 2016
• Vice-chair, The Ohio State University Radiation Safety Committee July 2014 – June 2015
• Medical Director of James Network Development, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, September 2015 – June 2017
• Member, James Cancer Hospital OR Committee, 2006 – present
• Member, The Ohio State University Wexner Medical Center Credentials Committee, 2010 – present
• Member, The Ohio State University Wexner Medical Center IHIS (Epic) Physician Advisory Committee, 2011 – present
• Member, The Ohio State University Radiation Safety Committee, 2013 – present
• The Ohio State University Wexner Medical Center Crew Resource Management Steering Committee, 2014 – 2019
• Member, Nationwide Children’s Hospital Cancer Committee, 2014-2019
• James Executive Clinical Management Team, January 2011 – December 2013
• The Ohio State University Faculty Council, 2010 – 2014
• The Ohio State University Medical School Learning Community Leader, 2009 – 2017
• The Ohio State University Physician Practice Patient Affairs Committee, 2008 – 2011
• James Cancer Hospital Medical Staff Affairs Committee, 2007 – 2009, 2011 – 2013
• James Cancer Hospital Quality Assurance Subcommittee, 2006 - 2011
• Radiation Oncology Department Head, John D. Cronin Cancer Center, Lexington, Kentucky, July 2003 – November 2006
• Radiation Oncologist, John D. Cronin Cancer Center, Lexington, Kentucky, July 2002 – November 2006
• Division Head, Radiation Oncology, Naval Medical Center, Portsmouth, Virginia, March 1999 – June 2002
• Staff Radiation Oncologist, Naval Medical Center, Portsmouth, Virginia, August 1995 – February 1999

Service to ASTRO

• Chair, ASTRO Clinical Affairs and Quality Committee, October 2020 - present
• Member, ROI Development Committee, 2021 - present
• Vice-chair, ASTRO Clinical Affairs and Quality Committee, October 2018 – October 2020
• Co-chair, ASTRO APEx Practice Accreditation Committee, April 2016 – October 2018
• Member, APEx Practice Accreditation Committee, September 2014 – October 2018
• APEx physician surveyor, September 2014 – present
• Member, ASTRO History Committee, 2006 - 2010
• Member, ASTRO Nuclear/Radiologic Response Committee, 2006 - 2010

Service to Other Oncology or Radiation Oncology Organizations

• NRG Cervix Committee member, January 2012 – January 2020
• American College of Radiology Surveyor, Radiation Oncology, March 2012 - July 2014
• GOG, Radiation Oncology Committee member, 2010 - 2014
• RTOG, Member VA/MTF Committee, 2001 – 2002
• Member, Department of Defense Breast Cancer Treatment Guideline Consensus Panel, 1998
• Recertification Exam for Radiation Oncology, Member, Item Writing Task Force, American Board of Radiology, 1996 – 2002
• Written Exam for Radiation Oncology, Member, Item Writing Task Force, American Board of Radiology, 1999-2002

How would ASTRO’s Strategic Plan inspire you (your leadership) as an ASTRO Board Member?

Central to ASTRO’s stated mission is a commitment to the cultivation and education of a diverse workforce. Our strength as radiation oncologists lies in our deep commitment to our patients integrated with our insatiable curiosity for how we can continue to do things better than before. These are core values that need to be supported and nurtured in all possible ways. To be leaders in the field of oncology, we must not only maintain our current strengths – to develop technology, embrace new treatment paradigms, and conduct meaningful research – but we must also continue to identify and implement pathways toward progress.

Innovation should also be a guiding principle that we support and nurture in our approach to education. How we educate ourselves – and, critically, how we educate and support the future workforce of our specialty – defines who we are. By investing in education for all of ASTRO’s members, including those currently in training or early in their careers, we have the opportunity to ensure radiation oncologists are considered central leaders alongside our medical and surgical colleagues for decades to come.

As the Education Council Vice-chair and ASTRO Board Member, I would aim to assure that the voices of all members are represented. I would prioritize engagement from longstanding ASTRO members as well as newer members who will be tasked with guiding the Society over the decades to come. Differences of opinion should be embraced and recognized as a contributor to creativity. I believe that we are at our best when we prioritize transparency, open discussion and inclusivity.

Chelsea C. Pinnix, MD, PhD, is an Associate Professor in the Department of Radiation Oncology at MD Anderson Cancer Center, specializing in the treatment of patients with hematologic malignancies. In addition to a commitment to patient care and clinical research, Dr. Pinnix is also passionate about education. She has served as the Associate Program Director of the residency program at MD Anderson Cancer Center between 2016 – 2020, and in 2020 she assumed the role of Program Director. At MD Anderson she serves as Chair of the Radiation Oncology Teaching and Quality Assurance Conference and the Co-chair of the Division of Radiation Oncology Grand Rounds Selection Committee.
 
Dr. Pinnix has been an Active Member of ASTRO since 2013 and has a history of service to ASTRO and education. She has served on the Annual Meeting Lymphoma Track Committee since 2014, acting as the Vice-chair of this committee since 2020. Since 2021, she has participated as a member of the Annual Meeting Scientific Committee. She was a member of the ASTRO CME-MOC Committee between 2015-2020. Currently she is the Vice-chair of the Association of Directors of Radiation Oncology Program (ADROP) and serves on the ASTRO Workforce Task Committee.
 
In addition to her service on ASTRO committees, she acted as Associate Editor for the Hematologic Malignancy Section of the Red Journal between 2015-2017, and then served as Senior Editor of this section until 2020.  She is a category member and board examiner of the hematologic malignancy section for the ABR, an exam writer for the Lymphoma/Leukemia Section for the ACR In-Training Examination for Radiation Oncology, and a steering committee member of the International Lymphoma Radiation Oncology Group (ILROG). 

Education

• MD, University of Pennsylvania, Philadelphia, 2007
• PhD, University of Pennsylvania, Philadelphia, 2005
• BS, University of Maryland Baltimore County, Baltimore, Biochemistry (Magna Cum Laude, Meyerhoff Program Scholar), 1999

Postgraduate Education

• Resident, Radiation Oncology, MD Anderson Cancer Center, Houston, 2008 - 2012
• Internship, Internal Medicine, Johns Hopkins University, Sinai Hospital, Baltimore, 2007 – 2008

Academic Appointments

• Associate Professor, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, 2018 - present
• Assistant Professor, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, 2012 - 2018
• Voluntary Clinical Associate Professor, University of Houston College of Medicine (UHCOM), 2021- present

 Administrative Appointments

• Residency Program Director, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, 2020 – present
• Residency Associate Program Director, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, 2016 - 2020
• Co-chair, Division of Radiation Oncology Grand Rounds Committee, Department of Radiation Oncology, Division of Radiation Oncology, MD Anderson Cancer Center, Houston, 2020 - present
• Chair, Department of Radiation Oncology, Division of Radiation Oncology, Division of Radiation Oncology Teaching & QA Conference, Houston, 2020 - present
• Chair, Department of Radiation Oncology Residency Program Clinical Competency Committee, 2018 - 2020

 Service to ASTRO

• Member, ASTRO Workforce Task Force Committee, 2021- present
• Vice-chair, Annual Meeting Track Committee, Hematologic Malignancies, 2020 – present
• Member Annual Meeting Scientific Committee, 2020 – present
• Vice-President, Association for Directors of Radiation Oncology (ADROP), 2021 - present
• Director at Large, Association for Directors of Radiation Oncology (ADROP), 2020 - 2021
• Member, Red Journal Editor in Chief Search Committee, 2019 - 2020
• Senior Editor, Red Journal Editorial Board, Hematologic Malignancies, 2018 - 2020
• Associate Editor, Red Journal Editorial Board, Hematologic Malignancies, 2015 - 2017
• Member, CME/MOC Committee, 2015 - 2020
• Member, Annual Meeting Track Committee, Hematologic Malignancies, 2014 – 2020

 Service to Other Oncology or Radiology Organizations

• National American College of Radiology (ACR)
  • In-Training Exam Test Writer for Lymphoma/Leukemia, 2020 - 2021
  • Member, 2012-present
• NCI Lymphoma Steering Committee
  • Member, 2022 - present
• International Lymphoma Radiation Oncology Group (ILROG)
  • Steering Committee Member, 2019-present
  • Council Member, 2015-2019
  • Member, 2014-2015
• Southwest Oncology Group (SWOG)
  • Myeloma Committee-Radiation Oncology Chair, 2016-present
  • Radiation Oncology Committee Member, 2016-present
  • Member, 2016-present
• American Radium Society (ARS)
  • Scientific Program Chair, 2021 Annual Meeting
  • Member at Large, 2021-present
  • Member, Awards Committee, 2021-2022
  • Member, Appropriateness Criteria Panel for Lymphoma, 2017-present
  • Member, 2017-present
• Radiological Society of North America (RSNA)
  • Member, 2017-present
  • Member, Oncologic Imaging and Therapies Task Force/Lymphoma Boost Course Organizer, 2017-2021
• American Board of Radiology (ABR)
  • Continuing Certification (CC) Advisory Committee, 2021 - present
  • Member, MOC Advisory Committee (RO), 2021 - present
  • Member, RO Oral Lymph, 2021 – present
  • Oral Examiner, RO Oral Examiners, 2019 - present
  • SAMs Reviewer, MOC RO SAMs, 2018 - 2019
  • Lymphoma/Leukemia/Myeloma Category Member, 2018-present
• American Association for Women Radiologists (AAWR)
  • Treasurer, 2014- 2015
  • Secretary, 2013- 2014
  • Chair, Radiation Oncology Committee, 2012 – 2013
  • Chair, Members in Training Committee, 2010 - 2012

How would ASTRO’s Strategic Plan inspire you (your leadership) as an ASTRO Board Member?

When I attended my first ASTRO Advocacy Day in 2008, I was a newly minted PGY-2, just learning the language and technical art of our field. I was immediately drawn to the efforts to represent radiation oncology through Congressional relations. While I may not have really understood the concept of percent depth dose curves or beam profiles yet, I did recognize the importance of advocating for our amazing specialty and patients at all levels of our government. The last decade plus has certainly seen challenges and kinetic road blocks to the betterment of our field. I have chosen to focus my GR efforts on how I think ASTRO can best represent our members: advocating for reimbursement stability, an end to prior authorization overreach and abuses, increased funding support for radiation oncology research as well as recognition of the challenges facing radiation oncology teams in medically underserved communities. I hope my work on the ASTRO board will lead to expanded member involvement in advocacy efforts; I am particularly focused on engaging members in community based practices as well as those members in training.

I am a private practice radiation oncologist working with Tennessee Oncology, a large multispecialty oncology group based in Nashville. I feel extraordinarily lucky to be able to practice medicine in my hometown with great family support. When not working in clinic or volunteering for ASTRO, I am likely at home juggling life with two small children and three poorly behaved dogs. I excel at hobbies including shoe shopping, kindergarten art projects and binge-watching true crime series. I do not excel at tennis, but I am trying.

Education

• MD, University of Tennessee, College of Medicine, Memphis, 2002-2006
• Graduate Internship in Molecular Biology, Imperial College of Medicine, England, 2001-2002
• BA, English Literature and Molecular Biology, Carson Newman College, Jefferson City, Tennessee, 1997-2001

Postgraduate Education

• Resident, Radiation Oncology, Loyola University Medical Center, Chicago, 2007-2011
• Internship, Internal Medicine, University of Tennessee, Memphis, 2006-2007

Academic Appointments

• Assistant Professor, Radiation Oncology, Duke University Medical Center, Durham, North Carolina, 2012-2014
• Medical Instructor, Radiation Oncology, Duke University Medical Center, Durham, North Carolina, 2011-2012

Hospital Appointments

• Managing Partner, Radiation Oncology, Tennessee Oncology, Nashville, Tennessee, 2014-present
• Managing Partner, Radiation Oncology, Tennessee Oncology, Nashville, Tennessee, 2018 – present
• Board Member, Tennessee Oncology, Nashville, Tennessee, 2018 – present
• Chief and Medical Director of Radiation Oncology, Ascension St. Thomas, Tennessee Oncology, Nashville, Tennessee, 2020 – present
• Medical Director, Radiation Oncology, Centennial Medical Center, Tennessee Oncology, Nashville, Tennessee, 2019 – 2020
• Medical Director, Radiation Oncology, Stonecrest Medical Center, Tennessee Oncology, Nashville, Tennessee, 2014 – 2019

Service to ASTRO

• Chair, ASTRO Government Relations Committee, 2020-present
• Co-chair, ASTRO PAC, 2019-present
• Member, ASTRO Government Relations Committee, 2014-present
• State Captain, ASTRO Government Relations Council, 2012-2020
• Member, ASTRO Scientific Content Review Subcommittee, 2013-2015
• Member, ASTRO Webinar Task Force, 2013-2015
• Member, ASTRO CME Task Force, December 2010-2014
• Member, ASTRO Education Committee, March 2008-2014
• Immediate Past Chair, Executive Committee – Association of Residents in Radiation Oncology (ARRO), March 2010-2011
• Chair, Executive Committee – ARRO, March 2009-2010
• ASTRO Delegate, American Medical Association – RFS Delegation, 2008-2010
• Junior Board Member, Executive Committee – ARRO, March 2008-2009

Service to Other Oncology or Radiology Organizations

• Medical Director, ONE Liver program, 2021–present
• Member, Medical Staff Advisory Committee, Ascension St. Thomas, 2020–present
• Medical Liaison Physician, ACOS Cancer Committee, Ascension St Thomas, 2020–present
• Chair, One Oncology Radiation Oncology Committee, 2020–present
• Member, One Council (clinical leadership council for One Oncology), 2020–present
• Co-chair, Sarah Cannon Breast Workgroup, 2018–2020
• Co-chair, Sarah Cannon Radiation Oncology Executive Committee, 2015–2020
• Director, Sarah Cannon Radiation Oncology Market Work Group, 2015–2017
• Member, American College of Radiation Oncology (ACRO) Women’s Caucus, March 2009–2011

How would ASTRO’s Strategic Plan inspire you (your leadership) as an ASTRO Board Member?

Health equity is essential for clinical excellence. In its strategic plan of 2017, ASTRO set the precedent of raising diversity and inclusion as strategic priorities alongside other longstanding values of clinical excellence, innovation, improved outcomes and organizational integrity. This vision aligns closely with the belief that as health providers, achieving health equity should factor highly among our most noble reasons for practicing our science and art in medicine. A pillar of these values is radiation oncology workforce diversity which assures that the providers meet the need of the rapidly diversifying demographics of the communities served. With a lens of inclusion, all policies and practices from membership recruitment to educational topics and advocacy should be informed by a full range of constituents and raise the visibility of those historically marginalized and less represented across ethnic/racial groups, gender and gender identity to include sexual gender minorities and persons with disabilities.

As stated in the ASTRO strategic plan, “ensuring that all patients who benefit from radiation receive it” is a goal toward improving access and achieving equitable care for patients. With advancements in multimodality therapy, cancer outcomes have dramatically improved resulting in over 3.5 million cancer deaths averted between 1991 and 2019 (American Cancer Society). Despite these observations, disparities persist along racial and socioeconomic lines. Radiation oncology has garnered much scrutiny in recent years for skyrocketing utilization of high-valued advanced therapies and burgeoning costs without commensurate improvements in health outcomes. The degree to which health disparities are reduced and eliminated must be regarded not only as measures of quality in our field but also should become the policies for which ASTRO consistently advocates.

As an ASTRO Board member, I will work collaboratively with officers and other councils to provide the perspectives of diversity, justice, inclusion and equity to all matters placed before the board for consideration.
 

I am committed to clinical excellence, innovation, diversity, equity and inclusion. As a board-certified radiation oncologist who specializes in stereotactic radiosurgery and radiation neuro-oncology, my clinical practice and research focuses on the radiation management of adult and pediatric brain and spinal tumors. I served as the founding Co-Director of the Stanford Radiosurgery Program pioneering the robotic radiosurgery for clinical utilization. I have spent my academic career as an investigator and clinician conducting clinical and translational research as the senior radiation oncologist of the Stanford Cancer Institute and Lucile Packard Children's Hospital Pediatric Brain Tumor team. Implementing strategies toward radiation oncology workforce diversity and health equity is a key area of my academic scholarship and service. With a strong track record of administrative leadership in roles in clinical arenas and in education as a former radiation oncology residency program director, I am now the Associate Dean of medical student admissions. In this role, I have employed mission-driven strategic leadership and innovative approaches such as holistic admissions to improve diversity and enhance the learning environment. At Stanford Medicine, I also serve as Chair of the Stanford Medicine Faculty Senate subcommittee on diversity, member of the Diversity Cabinet, the Medical Executive Committee and on the Executive Committee for Continuous Quality Improvement.

Education

• MD, Stanford University School of Medicine (Stanford Medicine), Stanford, California
• BS, Chemistry (Cum Laude), University of Delaware, Newark, Delaware

Postgraduate Education

• Resident, Radiation Oncology, Stanford University Medical Center, Stanford, California
• Transitional Internship, Highland Hospital Alameda County Medical Center, Oakland, California

Academic Appointments

• Professor, Radiation Oncology, Stanford Medicine, Stanford, California, 2017 - present
• Professor, Neurosurgery, by courtesy, Stanford Medicine, Stanford, California, 2017 - present
• Associate Dean, Medical Student Admissions, Stanford Medicine, Stanford, California, 2014 - present
• Associate Professor, Radiation Oncology, Stanford Medicine, Stanford, California, 2007 - 2017
• Assistant Professor, Radiation Oncology, Stanford Medicine, Stanford, California, 2000 - 2007

Hospital Appointments

• Stanford Healthcare, Stanford, California, 2000 - present
• Lucile Packard Children’s Hospital, Palo Alto, California, 2000 - present
• Palo Alto Veteran’s Administration Hospital, Palo Alto, California, 2000 - present
• Senior Associate Consultant, Mayo Clinic Scottsdale, Instructor, Mayo Medical School, 1991

Service to ASTRO

• Plenary Session Chair, Annual Meeting, 2021
• Advisor, Committee on Health Equity, Diversity and Inclusion, 2020 - 2021
• Member, Annual Meeting CNS Track, 2018 - 2019
• Member, Education Committee, 2017 - 2019
• Member, History Committee, 2010 - 2015
• Member, Editor Selection Task Force, 2010 - 2011
• Plenary Discussant, Annual Meeting, 2008, 2014
• CNS Track Chair, Scientific Program Committee, 2006 - 2007
• Reviewer, Abstract Review 2006 - 2007

Service to Other Oncology or Radiology Organizations

• American Board of Radiology
  • Continuing Certification Advisory Committee, 2022 - present
  • Chair, Pediatric sub-committee, 2015 - 2020
  • Oral examiner (PEDS/CNS), 2012 - present
  • Written exam committee, 2012 - 2019
• American College of Radiology
  • Councilor for California, 2022
  • Council on Regional Radiation Oncology Societies (CARROS), Executive Board, 2019 - present
  • Alternate Councilor for California, 2019 - present
  • Human Resources Commission, 2019 - present
  • Commission for Women and Diversity, 2018 - 2022
• Radiological Society of North America
  • Plenary Speaker, Annual Radiation Oncology Oration, 2021
  • Public Information Committee (PIC), 2013 - 2019
• The Radiosurgery Society
  • Chairperson, 2021 - 2023
  • President, 2019 - 2021
  • Executive Board, 2018 - present
• American Association for Women Radiologists
  • Radiation Oncology Committee, 2010
  • Awards Nomination Committee, 2012 - 2017
  • Membership Committee, 2014 - 2017
• National Medical Association Section on Radiology and Radiation Oncology 2009 - present
  • Executive Board-past Chair, 2009 - 2020
  • Program Chair, 2014 - 2016
• American Radium Society
  • Annual Scientific Meeting Oral Session, Chair, 2009
  • Annual Scientific Meeting CNS track, Member, 2007
• International Stereotactic Radiosurgery Society
  • Congress Scientific Planning Committee, Chair, 2009

How would ASTRO’s Strategic Plan inspire you (your leadership) as an ASTRO Board Member?

ASTRO identified Diversity and Inclusion (D&I) as a core value in their 2017 Strategic Plan. Through the Strategic Plan, we have the opportunity to operationalize a commitment to diversity, inclusion, health equity and belonging. I have dedicated the past 14 years to advancing DEI within ASTRO and Radiation Oncology through my direct committee work to the benefits of our patients, members, trainees and the communities that we serve. I look forward to continuing to spearhead these efforts on the Board with the collaboration of the Council leaders, their committees, and the ASTRO staff and volunteers. By strengthening, initiating and harmonizing diversity efforts across the Society and its Councils, cohesion, efficiency, resource utilization and efficacy will be improved contributing to clinical care, quality and safety, policy, and research broadly.  To the extent of its power and potential, ASTRO can innovate and transform to become a leader in achieving diversity, fostering inclusion and adequately addressing health equity.

Dr. Curtiland Deville is an Associate Professor in the Department of Radiation Oncology and Molecular Radiation Sciences at the Johns Hopkins University School of Medicine. He serves as Clinical Director of Sibley Radiation Oncology and Medical Director of the Johns Hopkins Proton Therapy Center.
 
Dr. Deville’s clinical expertise involves treating patients with prostate cancer and soft tissue sarcoma. His funded research interests include improving tumor targeting and assessing toxicity profiles using modern radiation techniques such as proton and photon therapy. He has co-authored over 140 peer-reviewed publications and serves as a Deputy Editor for the International Journal of Radiation Oncology, Biology, Physics.
 
Dr. Deville has a research interest in physician workforce diversity as a means to address health equity. He is a leading advocate for health equity, diversity, and inclusion (HEDI) in Radiation Oncology. He serves as the Immediate Past Chair of the American Society for Radiation Oncology’s (ASTRO) Committee on HEDI and was recently appointed to the ASTRO Board of Directors as an ex-officio member.
 

Education

• MD, Brown Medical School, Providence, Rhode Island, 2005
• BA, Human Biology, Human Health and Disease, Brown University, Providence, Rhode Island, 2000

  Postgraduate Education

• Resident, Radiation Oncology, Hospital of the University of Pennsylvania, Philadelphia, 2006-2010
• Transitional Intern, Internal Medicine, Harbor Hospital Center, Baltimore, 2005-2006

  Academic Appointments

• Associate Professor, Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University, 2017-present
• Assistant Professor, Department of Radiation Oncology, University of Pennsylvania, 2010-2015
• Assistant Professor, Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University, 2015-2017      

  Hospital Appointments

• Medical Director, Johns Hopkins Proton Therapy Center, Sibley Memorial Hospital, Johns Hopkins Medicine, 2020-present
• Chair, Sibley Radiation Oncology, Sibley Memorial Hospital, Johns Hopkins Medicine, 2018-present
• Clinical Director, Sibley Radiation Oncology, Sibley Memorial Hospital, Johns Hopkins Medicine, 2016-present 
• Chief, Genitourinary and Sarcoma Services, Department of Radiation Oncology, University of Pennsylvania, 2014-2015

  Service to ASTRO

• Annual Meeting Steering Committee, 2022
• Associate Editor, Advances in Radiation Oncology, 2015-2018
• Senior GU Editor, Advances in Radiation Oncology, 2018-present
• ASTRO Annual Meeting Health Services Research Track Reviewer, 2016-2019
• Committee for Health Equity, Diversity, and Inclusion, 2008-present
  • 2014-2016 Vice-chair,
  • 2016-2019 Chair,
  • 2019-2021 Immediate Past Chair
  • 2020-2022 Ex Officio Member, ASTRO Board of Directors

Service to Other Oncology or Radiology Organizations

• PTCOG GU Subcommittee Member, 2020-present
• Radiation Oncology Education Collaborative Study Group (ROECSG) Core Curriculum Committee, 2020-present
• Committee Member, American College of Radiology (ACR), Commission for Women and General Diversity, Steering Committee PIER pipeline program, 2013-present
• Young Physician Representative, Council of Affiliated Regional Radiation Oncology Societies (CARROS), ACR, 2015-2017
• Committee Member, Health Equity Committee, American Society of Clinical Oncology (ASCO), 2016-2019
• ACR Radiation Oncology In-Training (TXIT^TM) Exam Bone/Soft Tissue Sarcoma Section, Test Item Writing Activity for the ACR TXIT^TM, 2017-2021
• ACR Radiation Oncology In-Training (TXIT^TM) Exam GU Section, Test Item Writing Activity for the ACR TXIT^TM, 2021
• Subcommittee Chair, Diversity in Oncology Initiative, Health Equity Committee, ASCO, 2018-2020